Responsive image

Common name


(2R)-2-methylpyrrolidine

IUPAC name


(2R)-2-methylpyrrolidine

SMILES


CC1NCCC1

Common name


(2R)-2-methylpyrrolidine

IUPAC name


(2R)-2-methylpyrrolidine

SMILES


CC1NCCC1

INCHI


InChI=1S/C5H11N/c1-5-3-2-4-6-5/h5-6H,2-4H2,1H3/t5-/m1/s1

FORMULA


C5H11N

Responsive image

Common name


(2R)-2-methylpyrrolidine

IUPAC name


(2R)-2-methylpyrrolidine





Molecular weight


85.148

clogP


1.392

clogS


-1.089

Frequency


0.0014





HBond Acceptor


0

HBond Donor


1

Total Polar
Surface Area


12.03

Number of Rings


1

Rotatable Bond


0

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00271 Sulpiride Responsive image Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dopamine Antagonists; Antidepressive Agents; Nervous System; Psycholeptics; Benzamides; Sulpiride is indicated for the treatment of schizophrenia.
FDBD00288 Remoxipride Responsive image Antipsychotic Agents; Dopamine Antagonists; Nervous System; Psycholeptics; Benzamides; CYP2D6 Inducers; CYP2D6 Inducers (strong); Remoxipride is an atypical antipsychotic once used for the treatment of schizophrenia.
FDBD01200 Alizapride Responsive image Antiemetics; Prokinetic Agents; Alimentary Tract and Metabolism; Drugs for Functional Gastrointestinal Disorders; Propulsives; Alizapride is used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.
FDBD01388 Doripenem Responsive image Doripenem is indicated in the treatment of complicated intra-abdominal infections and complicated urinary tract infections, including pyelonephritis, caused by designated susceptible bacteria.
4 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
3fh5_ligand_1_4.mol2 3fh5 1 -6.56 C[C@H]1CCC[NH2+]1 6
3fun_ligand_1_5.mol2 3fun 1 -6.56 [C@H]1([NH2+]CCC1)C 6
3fui_ligand_1_0.mol2 3fui 1 -6.51 C[C@@H]1[NH2+]CCC1 6
3fh7_ligand_1_4.mol2 3fh7 1 -6.32 C[C@@H]1CCC[NH2+]1 6
2g5p_ligand_1_1.mol2 2g5p 1 -6.07 C[C@H]1CCC[NH2+]1 6
2ghg_ligand_1_0.mol2 2ghg 1 -6.07 [C@@H]1(CCC[NH2+]1)C 6
2g5t_ligand_1_1.mol2 2g5t 1 -5.95 C[C@H]1CCC[NH2+]1 6
2c1b_ligand_1_3.mol2 2c1b 1 -5.94 C1C[NH2+][C@@H](C1)C 6
333 , 34